HTD Biosystems CSO Featured as Expert in AAPS Nanotechnology Session on Nanoparticle Characterization
We’re proud to announce that Dr. Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, was selected as one of the featured experts in the "Ask the Experts" session on Nanoparticle Characterization, organized by the AAPS Nanotechnology Community on January 27, 2025. This session brought together leading scientists to discuss cutting-edge techniques and best practices in the characterization of nanoparticles, critical for advancing nanomedicine and biologics.
Dr. Mosharraf shared insights drawn from over 24 years of experience in biologics and nanomedicine development, focusing on innovative strategies for ensuring the stability, efficacy, and quality of nanoparticle-based formulations.
At HTD Biosystems, we specialize in nanoparticle characterization and formulation development, offering comprehensive services for liposomes, lipid nanoparticles (LNPs), antibody-drug conjugates (ADCs), and other complex modalities. Our expertise in Design of Experiments (DoE) and advanced analytical techniques ensures robust, reproducible results, accelerating your drug development process from bench to clinic.
Ready to optimize your nanoparticle formulations?
Contact us today to learn how our expert team can support your next breakthrough.